共 50 条
- [32] Relationship Between Anifrolumab Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Moderate to Severe Systemic Lupus Erythematosus [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (09): : 1094 - 1105
- [40] QT dispersion increases in patients with systemic lupus erythematosus [J]. Clinical Rheumatology, 2007, 26 : 376 - 379